menu
    • menu
    [{"orgOrder":0,"company":"PinCell","sponsor":"Scinai Immunotherapeutics","pharmaFlowCategory":"D","therapeuticArea":"Immunology","country":"ITALY","productType":"Antibody","year":"2025","type":"Agreement","leadProduct":"PC111","moa":"FasL","graph1":"Immunology","graph2":"Preclinical","graph3":"PinCell","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Immunology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"PinCell \/ Scinai Immunotherapeutics","highestDevelopmentStatusID":"4","companyTruncated":"PinCell \/ Scinai Immunotherapeutics"}]

    Find Clinical Drug Pipeline Developments & Deals by PinCell

    Menu

    PinCell

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            PinCell

                            Italy arrow
                            WRIB
                            Not Confirmed

                            PinCell

                            Italy arrow
                            WRIB
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : PC111

                            Therapeutic Area : Immunology

                            Study Phase : Preclinical

                            Sponsor : Scinai Immunotherapeutics

                            Deal Size : Undisclosed

                            Deal Type : Agreement

                            DEALS_DEV arrow-down

                            Scinai Signs an Option Agreement to Acquire Rare Disease Company Pincell

                            Details : The agreement aims for the acquisition of Pincell and its monoclonal antibody, PC111, that binds to the human soluble Fas ligand and thus blocks its activation of apoptosis of skin cells.

                            Product Name : PC111

                            Product Type : Antibody

                            Upfront Cash : Undisclosed

                            March 27, 2025

                            Lead Product(s) : PC111

                            Therapeutic Area : Immunology

                            Highest Development Status : Preclinical

                            Sponsor : Scinai Immunotherapeutics

                            Deal Size : Undisclosed

                            Deal Type : Agreement

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth